Hangzhou Zhongtai Cryogenic Technology Corporation
SZSE:300435.SZ
13.44 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,716.634 | 3,047.457 | 3,256.425 | 2,406.997 | 1,977.5 | 1,034.33 | 594.732 | 485.58 | 337.164 | 462.464 | 432.77 | 379.623 | 308.609 | 192.704 |
| Cost of Revenue
| 2,201.43 | 2,461.68 | 2,699.583 | 1,951.187 | 1,565.506 | 804.645 | 443.502 | 355.038 | 229.437 | 300.298 | 270.331 | 245.926 | 192.277 | 115.373 |
| Gross Profit
| 515.205 | 585.777 | 556.842 | 455.81 | 411.994 | 229.686 | 151.23 | 130.542 | 107.727 | 162.167 | 162.44 | 133.697 | 116.332 | 77.331 |
| Gross Profit Ratio
| 0.19 | 0.192 | 0.171 | 0.189 | 0.208 | 0.222 | 0.254 | 0.269 | 0.32 | 0.351 | 0.375 | 0.352 | 0.377 | 0.401 |
| Reseach & Development Expenses
| 52.986 | 64.126 | 59.817 | 40.383 | 19.198 | 25.594 | 23.504 | 15.657 | 15.337 | 14.177 | 12.952 | 11.506 | 9.099 | 6.995 |
| General & Administrative Expenses
| 41.024 | 42.745 | 46.682 | 43.288 | 39.8 | 33.816 | 33.096 | 15.652 | 8.344 | 9.292 | 6.975 | 4.892 | 7.961 | 3.573 |
| Selling & Marketing Expenses
| 15.951 | 39.719 | 41.218 | 40.081 | 31.736 | 22.534 | 11.939 | 10.245 | 11.881 | 8.493 | 9.822 | 7.459 | 7.25 | 5.004 |
| SG&A
| 56.976 | 82.464 | 87.9 | 83.37 | 71.536 | 56.35 | 45.035 | 25.897 | 20.225 | 17.785 | 16.797 | 12.351 | 15.211 | 8.577 |
| Other Expenses
| 428.808 | 7.559 | 53.335 | 41.93 | 46.752 | 29.491 | 3.474 | 21.676 | 1.108 | 10.843 | 3.589 | 0.559 | 2.589 | 0.233 |
| Operating Expenses
| 542.234 | 154.149 | 201.052 | 165.682 | 137.487 | 111.435 | 93.686 | 63.188 | 57.973 | 54.614 | 50.306 | 43.899 | 40.414 | 25.761 |
| Operating Income
| -27.03 | 431.629 | 344.992 | 305.857 | 268.57 | 138.123 | 68.572 | 49.118 | 65.371 | 97.318 | 90.302 | 76.965 | 60.115 | 42.211 |
| Operating Income Ratio
| -0.01 | 0.142 | 0.106 | 0.127 | 0.136 | 0.134 | 0.115 | 0.101 | 0.194 | 0.21 | 0.209 | 0.203 | 0.195 | 0.219 |
| Total Other Income Expenses Net
| 4.614 | -0.271 | 4.733 | 4.137 | 4.446 | -5.186 | 3.474 | 21.676 | 1.016 | 10.843 | 0.148 | -5.467 | 2.589 | -8.267 |
| Income Before Tax
| -22.415 | 431.357 | 355.083 | 311.064 | 269.444 | 94.22 | 72.046 | 70.794 | 66.479 | 108.161 | 93.891 | 77.524 | 62.704 | 42.399 |
| Income Before Tax Ratio
| -0.008 | 0.142 | 0.109 | 0.129 | 0.136 | 0.091 | 0.121 | 0.146 | 0.197 | 0.234 | 0.217 | 0.204 | 0.203 | 0.22 |
| Income Tax Expense
| 59.798 | 82.13 | 78.071 | 65.537 | 76.176 | 16.813 | 7.525 | 10.577 | 9.61 | 15.788 | 13.958 | 11.371 | 9.841 | 6.025 |
| Net Income
| -77.96 | 350.061 | 277.959 | 245.353 | 196.109 | 77.436 | 67.636 | 60.204 | 56.869 | 92.373 | 79.933 | 66.153 | 52.863 | 36.375 |
| Net Income Ratio
| -0.029 | 0.115 | 0.085 | 0.102 | 0.099 | 0.075 | 0.114 | 0.124 | 0.169 | 0.2 | 0.185 | 0.174 | 0.171 | 0.189 |
| EPS
| -0.2 | 0.92 | 0.73 | 0.65 | 0.52 | 0.29 | 0.28 | 0.25 | 0.24 | 1.23 | 0.44 | 0.37 | 0.29 | 0.2 |
| EPS Diluted
| -0.2 | 0.91 | 0.73 | 0.65 | 0.52 | 0.29 | 0.27 | 0.25 | 0.23 | 1.23 | 0.44 | 0.37 | 0.29 | 0.2 |
| EBITDA
| 113.303 | 559.22 | 459.5 | 403.289 | 348.294 | 127.267 | 75.465 | 92.035 | 78.835 | 121.891 | 110.201 | 93.846 | 79.527 | 59.373 |
| EBITDA Ratio
| 0.042 | 0.184 | 0.141 | 0.168 | 0.176 | 0.123 | 0.127 | 0.19 | 0.234 | 0.264 | 0.255 | 0.247 | 0.258 | 0.308 |